MTI Medical Idomarine

20+ Years of Iodine Intelligence:
Restoring Women's Hormonal Harmony

This year marks the 20th Anniversary of MTI Medical's pioneering research into Idomarine, a patented iodine polymer complex. To celebrate this milestone, we are launching a global awareness campaign focusing on the transformative power of iodine polymers in women's reproductive health and the critical role of the thyroid gland.

100% Menstrual Regularity
3 Product Formulations
100% Non-Hormonal
The Challenge: PCOS and Infertility

Polycystic Ovary Syndrome, or PCOS, affects millions of women worldwide, presenting a complex array of symptoms from irregular cycles to metabolic disturbances. For many, this journey is further complicated by infertility, a deeply personal and often distressing challenge. These conditions not only impact physical health but also significantly affect emotional well-being and quality of life.

What is Idomarine
MTI MEDICAL Therapeutic Breakthroughs: PCOS, Ovarian Cysts, and Fibrocystic Breast Disease

Over the last 25 years, MTI Medical has documented the "miracle" effects of Idomarine in treating conditions that were previously managed only through invasive surgery or hormonal contraceptives. At MTI Medical, we believe in empowering women through scientifically formulated solutions. Our vision is to provide targeted support that addresses the root causes of these challenges, helping women restore balance and achieve their reproductive health goals. This brings us to our flagship product line: Idomarine.

The Iodine Gap :
Iodine deficiency is a severe public health issue in Pakistan, with nearly 76% of women and 64% of school-going children affected. Despite 80% household usage of iodized salt, significant pockets of deficiency remain, especially in rural areas. The crisis causes cognitive impairment, goiter, and is linked to high rates of stillbirths.

Quick Facts

Primary Indication PCOS & Infertility
Key Ingredient Iodine Polymer
Product Variants 3 Formulations
Natural Sources Kelp & Red Algae
Treatment Type Non-Hormonal
Therapeutic Solution

Introducing Idomarine:
A Targeted Therapeutic Solution

Idomarine represents a meticulously engineered product line, formulated not merely as a nutritional supplement, but as a specialized therapeutic intervention. At its core is a unique iodine complex, clinically recognized for its profound and targeted impact on reproductive health.

🎯
PCOS Support
Navigates complexities
⚖️
Hormonal Balance
Restores equilibrium
🤱
Fertility Support
Optimizes function
Learn More About Idomarine
Idomarine Product Box
20 Capsules
The Miracle of Iodine

The human body has a sophisticated system for capturing and concentrating iodine, known as the Sodium-Iodide Symporter (NIS), or more commonly, the “Iodine Pump.” While the thyroid gland is the most famous user of this pump, the ovaries and mammary glands are the next most significant “iodine pumps” in the female body. It explains why these tissues are so iodine-dependent and how Idomarine (Iodine Polymer) leverages this mechanism to treat PCOS and ovarian cysts.The ovaries are the primary reproductive organs in women, responsible for both the production of gametes (oocytes) and the secretion of critical sex hormones. The transition from healthy ovarian physiology to the pathophysiology of ovarian cysts (particularly in PCOS) involves a profound disruption of hormonal harmony and cellular signaling.

HORMONAL IMBALANCE

The MTI Medical pilot study on Idomarine highlighted its effectiveness in regulating menstrual cycles and restoring hormonal balance in PCOS patients with subclinical hypothyroidism . This broader hormonal normalization can contribute to an improvement in androgen-related symptoms like hirsutism and acne.

Clinical Evidence: Idomarine in the Treatment of Hormonal Acne and Hirsutism. Polycystic Ovary Syndrome (PCOS) is a complex endocrine disorder characterized by hormonal imbalances that often manifest as hormonal acne and hirsutism (excessive hair growth). Recent clinical research, including a significant study involving 100 medical students at Sir Syed Medical College, has provided compelling evidence for the efficacy of Idomarine (Iodine Polymer) in managing these distressing symptoms 

hirsutism
The Clinical Impact on Hirsutism and Acne

One Deficiency. Eight Consequences. One Solution Idomarine

The Hidden Link: How Iodine Deficiency Destroys Hormonal Balance

The Thyroid: The "King of Glands" And Its Impact On Reproductive System

Often called the "King of Glands" or the "Master Regulator." While the pituitary sends the signals, the thyroid is the King because it executes the most vital functions:

1 Reproductive Sovereignty

The thyroid governs the "speed" of the reproductive system. If the King is weak (hypothyroidism), the ovaries cannot produce quality eggs, the cycle becomes irregular, and the body cannot maintain a pregnancy.

2 The Foundation of Health

Just as a kingdom fails without a strong king, the endocrine system collapses without a healthy thyroid. Iodine provides the "crown jewels"—the essential mineral that the King needs to rule effectively.

3 The Thyroid-Reproductive Axis

Understanding the Hormonal Connection and how thyroid hormones directly influence estrogen, progesterone, and fertility outcomes...

The Impact of Iodine Deficiency on Reproductive Health

A Comprehensive Review

Iodine is an essential micronutrient required for the synthesis of thyroid hormones — master regulators of metabolic and endocrine functions. Because the reproductive system is highly sensitive to hormonal balance, iodine deficiency can lead to significant impairments in fertility, pregnancy outcomes, and fetal development.

46% Longer time to conceive in women with urinary iodine below 50 µg/L
+50% Increase in iodine demand during pregnancy to support fetal growth
>30% Reduction in stillbirth and neonatal mortality with supplementation
No. 1 Globally preventable cause of cognitive impairment and brain damage

Section 01

Female Reproductive Health & Fertility

The female reproductive axis is intricately linked to thyroid function. Even mild to moderate iodine deficiency can disrupt hormonal equilibrium and compromise fertility outcomes.

  • Delayed Conception: Women with urinary iodine below 50 µg/L take up to 46% longer to achieve pregnancy.
  • Ovulatory Dysfunction: Iodine deficiency induces subclinical hypothyroidism, leading to anovulation and cycle irregularities.
  • Oligomenorrhea: Infrequent menstrual periods due to disrupted FSH and LH gonadotropin secretion.
  • Abnormal Bleeding: Hormonal imbalances from reduced thyroid activity cause polymenorrhea and heavy menstrual bleeding.

Iodine requirements rise by approximately 50% during pregnancy. Failure to meet this demand carries serious risks for both the mother and the developing fetus.

  • Spontaneous Abortion: Women in iodine-deficient regions face significantly higher first-trimester miscarriage rates.
  • Stillbirth: Chronic deficiency is linked to stillbirths due to placental insufficiency and developmental arrest.
  • Perinatal Mortality: Supplementation in deficient populations reduces stillbirth and neonatal mortality by over 30%.
  • Preterm Birth: Low maternal iodine status is an established risk factor for premature delivery.

Section 03

Fetal & Neonatal Development

The fetus depends entirely on maternal thyroid hormones during the first trimester, making adequate iodine status critical from the moment of conception.

  • Neurological Impairment: Deficiency causes irreversible cognitive deficits, reduced IQ, and in severe cases, Cretinism.
  • Impaired Fetal Growth: Maternal iodine status directly determines birth weight, length, and developmental parameters.
  • Neonatal Hypothyroidism: Infants born to deficient mothers are at high risk and require immediate clinical intervention to prevent permanent disability.
Summary of Clinical Effects Based on peer-reviewed clinical research
Category Primary Effects of Iodine Deficiency
Fertility Prolonged time to conception, anovulation, reduced fecundability, and menstrual cycle irregularities.
Menstrual Health Oligomenorrhea, polymenorrhea, heavy uterine bleeding, and hormonal imbalances.
Pregnancy Elevated risk of miscarriage, stillbirth, gestational hypertension, pre-eclampsia, and preterm labour.
Fetal Health Impaired brain development, Cretinism, intrauterine growth restriction, and neonatal hypothyroidism.

Full Research Article

Read the complete clinical review

Full references, clinical data, methodology, and in-depth analysis are available in the complete article.

Read Full Article →
Iodine Polymer Complex Patent #141316 DRAP Reg. #505620098 25 Years Pakistani R&D

IDOMARINE
Mechanism of Action

Pathophysiological Pathways in PCOS · Ovarian Cysts · Fibrocystic Breast Disease · Acne & Hirsutism

IDOMARINE INPUT
Iodine Polymer Complex: I₂ + KI + Ascorbic Acid + Kelp Extract + Myoinositol
🧬
Pathway 1
Thyroid-Ovarian Axis Normalization
  • Restores Ovarian Iodine Content — ovaries hold 2nd highest iodine concentration after thyroid
  • Resolves Cystic Changes — iodine deficiency directly mimics PCOS-like ovarian pathology
  • Regulates TSH — corrects subclinical hypothyroidism (target 6–8 mIU/L)
  • Elevates SHBG — thyroid hormones increase Sex Hormone Binding Globulin levels
  • Binds Free Testosterone — SHBG reduces bioavailable androgen → ↓ Acne & Hirsutism
⚖️
Pathway 2
Hyperandrogenism Reduction
  • Myoinositol (Idomarine-M) — directly improves insulin sensitivity in PCOS
  • ↓ Hyperinsulinemia — reduces ovarian androgen production stimulus
  • Normalizes LH:FSH Ratio — corrects the typical PCOS endocrine imbalance
  • Stabilizes Endocrine Environment — balanced hormonal milieu for regular cycles
  • ↓ Ovarian Androgen Output — direct suppression of testosterone production
🌿
Pathway 3
Antioxidant & Anti-inflammatory
  • Kelp & Red Algae Extracts — natural iodine + potent antioxidant compounds
  • Neutralizes H₂O₂ & Radicals — oxidative stress is markedly elevated in PCOS
  • Reduces Skin Inflammation — soothes sebaceous gland inflammatory processes
  • Ascorbic Acid — enhances iodine absorption and cellular protection
  • Clearer Skin — dual anti-androgenic + anti-inflammatory mechanism
🫧
Iodine Polymer Action in
Ovarian Cysts & PCOS
1
Iodine Deficiency → Cyst Formation
Ovaries are the second richest iodine-storing organ. Deficiency causes abnormal estrogen sensitivity in follicular cells, leading to fluid accumulation and cyst development — mirroring thyroid nodule formation.
2
Iodine Polymer Replenishes Ovarian Stores
Molecular iodine (I₂) from the polymer complex is selectively taken up by ovarian epithelial cells via sodium/iodide symporter (NIS), restoring intracellular iodine concentrations to physiological levels.
3
Normalization of Estrogen Receptor Sensitivity
Iodine reduces estrogen receptor over-sensitivity in granulosa cells, decreasing abnormal follicular proliferation and fluid secretion that drives cyst enlargement.
4
Apoptosis Induction in Cystic Cells
I₂ activates programmed cell death pathways (PPARγ activation) in abnormally proliferating cystic epithelium, promoting cyst regression and volume reduction — confirmed on ultrasound.
5
Restoration of Folliculogenesis
Normalized ovarian iodine supports regular follicle development and ovulation, re-establishing LH:FSH equilibrium and leading to regular menstrual cycles.
↓ Ovarian Volume Cyst Regression Regular Cycles ↑ Fertility
🔵
Iodine Polymer Action in
Fibrocystic Breast Disease
1
Breast Tissue Iodine Dependency
Breast epithelial cells, like thyroid and ovarian cells, require adequate iodine for normal differentiation. Iodine deficiency causes ductal cells to become hypersensitive to estrogen, triggering abnormal proliferation and cyst formation.
2
Molecular Iodine Uptake by Breast Cells
I₂ (molecular iodine) is preferentially absorbed by breast ductal epithelium independently of the thyroid. It does not raise thyroid iodine load — making it thyroid-sparing while still active in breast tissue.
3
Anti-proliferative & Pro-apoptotic Effect
I₂ activates PPARγ nuclear receptors in breast epithelial cells, inducing differentiation and apoptosis of abnormally proliferating cells. This directly reduces fibrous tissue thickening and fluid-filled cyst development.
4
Estrogen Modulation in Breast Tissue
Iodine decreases the binding affinity of estradiol at estrogen receptors in ductal cells, reducing estrogen-driven proliferative signaling that causes nodularity, tenderness and cyst growth.
5
Oxidative Stress Reduction in Breast
Iodolipids (produced from I₂ in breast tissue) act as local antioxidants, neutralizing H₂O₂ and reducing oxidative damage to breast epithelium — a key driver of fibrocystic changes and mastalgia.
↓ Breast Tenderness Cyst Reduction ↓ Nodularity ↓ Mastalgia
All Three Pathways Converge to Produce:
Free Testosterone Reduction Elevated SHBG binds androgens + reduced ovarian production via improved insulin signaling
🔁
LH:FSH Ratio Normalization Restores regular follicular development and spontaneous ovulation
📉
↓ Androgenic Sebaceous Stimulation Less stimulation of glands and hair follicles → reduced acne and hirsutism
Cyst Regression (Ovarian & Breast) PPARγ-mediated apoptosis + iodine restoration reduces cystic volumes in both organs
🔄
Regular Menstrual Cycles
📊
Reduced Ovarian Volume & Cysts
🌱
Improved Fertility
Clearer Skin
🌸
Reduced Hirsutism
🔵
↓ Breast Tenderness & Nodularity
⚖️
Weight Reduction
🧘
Hormonal Balance
🩺
TSH Normalization
💊
Improved Insulin Sensitivity
Isra University
Karachi 2012

30 PCOS patients with subclinical hypothyroidism · Idomarine 50 mg BID · 8 weeks · Results showed return of regular cycles, reduced ovarian volume on ultrasound, and TSH normalization in the subclinical range with concurrent weight reduction.

8 wks
Return of regular ovulatory cycles observed in treated patients
6.6%
Conception rate within 6 months (pilot study — 2 confirmed pregnancies)
TSH ✓
Normalization in subclinical range (6–8 mIU/L) + weight reduction observed
🔬
Patented Polymer Technology
⚗️
Dual Iodine: I₂ + KI
🛡️
Thyroid-Sparing Molecular Iodine
🇵🇰
25 Years Pakistani R&D
DRAP Approved
Idomarine: Targeted Therapy for Fibrocystic Breast Disease and Apoptosis

Fibrocystic Breast Disease (FBD) is a common condition characterized by non-cancerous lumps, breast pain (mastalgia), and cysts. For decades, the primary management options were limited to pain relief or hormonal suppression. However, Idomarine (Iodine Polymer) has emerged as a targeted therapeutic that addresses the underlying physiological cause of FBD by inducing apoptosis (programmed cell death) in abnormal breast tissue and restoring hormonal balance.

.

Product Line

Tailored Solutions for Every Journey

Three scientifically formulated products designed to address different stages and aspects of women's reproductive health. Click any product to read the full clinical evidence.

Idomarine-M product box
IDOMARINE-M
10 Sachets
Read Clinical Evidence →

Idomarine-M

Advanced Complete Support

Comprehensive formulation adding Myoinositol for insulin sensitivity, L-Methyl Folate for reproductive health, and Vitamin D for hormonal regulation. Designed for complete PCOS management.

Key Ingredients:

  • Iodine Complex
  • Potassium Iodide
  • Vitamin C
  • Kelp, Red Algae
  • Myoinositol
  • L-Methyl Folate
  • Vitamin D (500000 I.U. per gram)
  • Manufacturer specifications

The Synergistic Power of Iodine & Myo-inositol for PCOS

  • Dual action on insulin resistance reduces androgen-driven acne & hirsutism
  • Restores FSH sensitivity and regular ovulation in PCOS
  • Idomarine polymer ensures stable, targeted iodine delivery
Read Article Frontiers in Endocrinology & PMC
Idomarine product box
IDOMARINE
20 Capsules
Read Clinical Evidence →

Idomarine

Foundation Formula

Essential support with Iodine Polymer, Potassium Iodide, Ascorbic Acid, Kelp, and Red Algae. Ideal for addressing iodine deficiency and supporting thyroid-ovarian balance.

Key Ingredients:

  • Iodine Polymer
  • Potassium Iodide
  • Vitamin C (Ascorbic Acid)
  • Kelp
  • Red Algae

The Impact of Iodine Deficiency on Reproductive Health

  • Women with low iodine take up to 46% longer to conceive
  • Iodine deficiency linked to anovulation & irregular cycles
  • Supplementation reduces stillbirth risk by over 30%
Read Article Isra University & Cochrane Library
Iodirin-F product box
IODIRIN-F
20 Capsules
Read Clinical Evidence →

Iodirin-F

Conception & Pregnancy

Focused formula with Potassium Iodide and L-Methyl Folate, crucial for early fetal development, neural tube defect prevention, and supporting healthy conception.

Key Ingredients:

  • Potassium Iodide
  • L-Methyl Folate (Active Folate)

The Power Duo: Iodine & Folic Acid for Fertility & Pregnancy

  • 12% improvement in fecundability with combined supplementation
  • L-Methyl Folate bypasses MTHFR mutations — superior bioavailability
  • 34% lower perinatal mortality with adequate iodine in pregnancy
Read Article S-PRESTO 2023 & Cochrane Library

Want to order or learn more?

Reach out to our team for pricing, documentation, or bulk enquiries.

MTI MEDICAL

Other Page

© 2019 MTI medical. All Rights Reserved

Find Us